KCT0005344已完成未知
Phase 2, Multi-center, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19?(Year) 至 0No Limit（—）
- 性别
- All
入选标准
- •1) Male or female =19 years old
- •2) Subjects with confirmed diagnoses of pneumonia caused by COVID-19 from:
- •Chest x-ray or computed tomography (CT) scan (findings of the increased opacity on a chest X-ray, ground-glass opacity indicative of pneumonia on CT, opinion on consolidation, etc.)
排除标准
- •1) Those who are diagnosed with viral pneumonia caused by other than COVID-19 or bacterial pneumonia during the screening
- •2) Patients with severe pneumonia according to the WHO guidance
- •Have fever or signs of respiratory infections
- •Satisfy any one of the following conditions: Respiratory rate > 30 breaths/min, severe respiratory distress, or room air oxygen saturation (SpO2) = 93%
研究者
相似试验
进行中（未招募）
1 期
Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) Given by Three Dosing Paradigms for the Reduction of Localized Subcutaneous Fat in the Submental AreaEUCTR2007-006303-21-GBKythera Biopharmaceuticals, Inc.60
进行中（未招募）
1 期
Clinical trial to compare the benefit and safety of a single infusion of VIS410, the study medicine added to standard Tamiflu® treatment to that of treatment with Tamiflu® alone in hospitalized adults with flu infection requiring oxygen supportInfluenza A infection in hospitalized patients who need supplemental oxygenMedDRA version: 20.1Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 100000004862EUCTR2016-004009-15-EEVisterra, Inc.120
进行中（未招募）
1 期
Clinical trial to compare the benefit and safety of a single infusion of VIS410, the study medicine added to standard Tamiflu® treatment to that of treatment with Tamiflu® alone in hospitalized adults with flu infection requiring oxygen supportInfluenza A infection in hospitalized patients who need supplemental oxygenMedDRA version: 20.1Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 100000004862EUCTR2016-004009-15-BEVisterra, Inc.120
进行中（未招募）
1 期
Clinical trial to compare the benefit and safety of a single infusion of VIS410, the study medicine added to standard Tamiflu® treatment to that of treatment with Tamiflu® alone in hospitalized adults with flu infection requiring oxygen supportEUCTR2016-004009-15-ESVisterra, Inc.390
进行中（未招募）
1 期
Clinical trial to compare the benefit and safety of a single infusion of VIS410, the study medicine added to standard Tamiflu® treatment to that of treatment with Tamiflu® alone in hospitalized adults with flu infection requiring oxygen supportInfluenza A infection in hospitalized patients who need supplemental oxygenMedDRA version: 20.0Level: LLTClassification code 10022002Term: Influenza A virus infectionSystem Organ Class: 100000015765EUCTR2016-004009-15-LVVisterra, Inc.390